521 related articles for article (PubMed ID: 28235245)
21. Organ-Specific MicroRNAs (
Taniguchi K; Sugito N; Shinohara H; Kuranaga Y; Inomata Y; Komura K; Uchiyama K; Akao Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695138
[TBL] [Abstract][Full Text] [Related]
22. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
Yan XL; Zhang XB; Ao R; Guan L
J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190
[TBL] [Abstract][Full Text] [Related]
23. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.
Yu G; Yu W; Jin G; Xu D; Chen Y; Xia T; Yu A; Fang W; Zhang X; Li Z; Xie K
Mol Cancer; 2015 Nov; 14():193. PubMed ID: 26576639
[TBL] [Abstract][Full Text] [Related]
24. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.
Dayton TL; Gocheva V; Miller KM; Israelsen WJ; Bhutkar A; Clish CB; Davidson SM; Luengo A; Bronson RT; Jacks T; Vander Heiden MG
Genes Dev; 2016 May; 30(9):1020-33. PubMed ID: 27125672
[TBL] [Abstract][Full Text] [Related]
25. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
Yadav S; Bhagat SD; Gupta A; Samaiya A; Srivastava A; Shukla S
BMC Cancer; 2019 Nov; 19(1):1031. PubMed ID: 31675998
[TBL] [Abstract][Full Text] [Related]
26. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
[TBL] [Abstract][Full Text] [Related]
27. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
[TBL] [Abstract][Full Text] [Related]
28. Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression.
Liu J; Zhi Q; Liu Y; Wang Y; Chen L; Ke Y; Zeng L; Wu X; Yang X; Guleng B; Liu H; Ren J
Exp Cell Res; 2021 Nov; 408(2):112872. PubMed ID: 34648844
[TBL] [Abstract][Full Text] [Related]
29. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
[TBL] [Abstract][Full Text] [Related]
30. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
31. Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer.
Kitayama K; Yashiro M; Morisaki T; Miki Y; Okuno T; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Hasegawa T; Sakurai K; Kubo N; Hirakawa K; Ohira M
Cancer Sci; 2017 Dec; 108(12):2462-2469. PubMed ID: 29032577
[TBL] [Abstract][Full Text] [Related]
32. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
[No Abstract] [Full Text] [Related]
33. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
Sun H; Zhu A; Zhang L; Zhang J; Zhong Z; Wang F
Int J Mol Sci; 2015 Oct; 16(10):24574-87. PubMed ID: 26501265
[TBL] [Abstract][Full Text] [Related]
35. miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
Zhang H; Feng C; Zhang M; Zeng A; Si L; Yu N; Bai M
J Cell Biochem; 2019 Mar; 120(3):2964-2972. PubMed ID: 30500994
[TBL] [Abstract][Full Text] [Related]
36. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
Jung Y; Jang YJ; Kang MH; Park YS; Oh SJ; Lee DC; Xie Z; Yoo HS; Park KC; Yeom YI
Mol Cells; 2013 Apr; 35(4):335-41. PubMed ID: 23515579
[TBL] [Abstract][Full Text] [Related]
37. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
38. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
[TBL] [Abstract][Full Text] [Related]
39. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.
Li H; Xu H; Xing R; Pan Y; Li W; Cui J; Lu Y
Pathol Res Pract; 2019 Jun; 215(6):152409. PubMed ID: 31000383
[TBL] [Abstract][Full Text] [Related]
40. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]